In Vitro Diagnostics Quality Control Market: Market Size & Forecast 2026

IVD quality control products encompass a range of materials, reagents, and software solutions designed to verify the accuracy and precision of diagnostic testing equipment and procedures in clinical laboratories. The market represents a specialized segment of the broader IVD industry, which was valued at approximately $109 to $157 billion in 2025 depending on the source. Market research firms consistently estimate the quality control niche at between $1.55 billion and $2.07 billion in 2025, with consensus projecting growth to roughly $2.15 billion by 2030 at a mid-single-digit compound annual growth rate.

• •2025 market size estimated at approximately $1.73 billion across industry reports, with projected 2030 values around $2.15 billion
• •Quality control products used to validate performance of IVD instruments, reagents, and testing procedures in clinical labs
• •Private market intelligence firms compile data independently; no government statistical agency publishes these specific figures

Laboratory accreditation and regulatory compliance requirements represent the single most significant catalyst for market expansion, as healthcare systems worldwide mandate ongoing quality assurance protocols. The rising global burden of chronic and infectious diseases has expanded diagnostic testing volumes, in turn increasing demand for quality control materials across more instruments and test menus. Additionally, the shift toward decentralized and point-of-care testing environments has broadened the customer base for QC products beyond traditional central laboratories.

• •Increasing laboratory accreditation demands across clinical and hospital labs driving consistent QC product procurement
• •Growing prevalence of diabetes, cardiovascular disease, cancer, and infectious diseases expanding global diagnostic test volumes
• •Adoption of advanced diagnostic technologies and multiplex testing platforms requiring more sophisticated quality control solutions

The market is typically segmented by product type, including quality control materials (liquid, lyophilized, or frozen), quality control software and data management solutions, and services. End-users span clinical laboratories, hospitals, diagnostic imaging centers, and academic and research institutions. Geographically, North America and Europe have historically represented the largest market shares due to established healthcare infrastructure and stringent regulatory frameworks, while the Asia-Pacific region is expected to see the fastest growth as healthcare access expands and laboratory modernization accelerates.

• •Product segments include control materials, QC software systems, and laboratory services and consulting
• •North America leads in market share due to advanced lab infrastructure and CLIA, CAP, and FDA regulatory requirements
• •Asia-Pacific emerging as fastest-growing region driven by healthcare investment, rising testing volumes, and lab accreditation adoption

What are the recent trends and outlook?

Digitalization and connectivity are reshaping the market, with cloud-based QC data management platforms enabling real-time monitoring, remote instrument surveillance, and predictive maintenance capabilities. The growing complexity of multiplex and molecular diagnostic assays is pushing manufacturers to develop more sophisticated multi-analyte control materials that span entire test menus. Over the 2025-2030 forecast horizon, the market is expected to maintain steady mid-single-digit growth, supported by continued regulatory tightening, laboratory consolidation trends, and expanding diagnostic testing in emerging economies.

• •Rise of digital QC and laboratory informatics platforms enabling real-time quality monitoring and regulatory compliance reporting
• •Increasing complexity of molecular and immunoassay testing driving demand for multi-analyte and commutable QC materials
• •Steady mid-single-digit CAGR of approximately 5-5.5% projected through 2030 as global lab standards continue to evolve